Feminine Intimate Care Comprehensive Study by Type (Wash, Wipes, Moisturizers & Creams, Shaving Gels, Others), Distribution Channel (Online Retailers, Hypermarket, Specialty Store), Form (Liquid, Gel, Foam, Others), End User (Women, Female Teens) Players and Region - Global Market Outlook to 2026

Feminine Intimate Care Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Feminine Intimate Care?
Feminine intimate care is intimate hygiene product especially made for women for cleansing, these intimate care products provide the genital area protection against any kind of infection by keeping it clean and also maintaining the pH value of 3.8. The intimate care helps in balancing the and supports the natural solution and helps in protecting against the harmful microorganisms providing better intimate hygiene and health. Feminine intimate care products include the intimate wash (liquid), wipes, creams, shaving gels, etc.

The market study is broken down by Type (Wash, Wipes, Moisturizers & Creams, Shaving Gels and Others) and major geographies with country level break-up.

Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bayer AG (Canesten) (Germany), The Procter & Gamble Company (United States), Johnson & Johnson (United States), Unilever (HUL) (United Kingdom), Sanofi (Lactacyd) (France), Himalaya Drug Company (India), Unicharm Corporation (Japan), Kimberly-Clark Corporation (United States), Nölken Hygiene Products GmbH (Germany) and Femina (Israel) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Feminine Intimate Care market by Type, Application and Region.

On the basis of geography, the market of Feminine Intimate Care has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online Retailers will boost the Feminine Intimate Care market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Liquid will boost the Feminine Intimate Care market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Women will boost the Feminine Intimate Care market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

On 24th March 2020, HUL acquires Glenmark's female hygiene brand VWash. Hindustan Unilever announced the acquisition of female intimate hygiene washes brand VWash from homegrown pharma major Glenmark Pharmaceuticals for an undisclosed sum.


Market Trend
  • Increasing Use of Intimate Wash Products Among Women
  • Rising Online Availability of Feminine Intimate Care Products

Market Drivers
  • Need for the Intimate Health Care to Avoid any Infections and other Serious Disease
  • Growing Awareness about the Intimae Health Care

Opportunities
  • Increasing Spendings of the Brands on Feminine Intimate Care Marketing and Advertisements

Restraints
  • Side Effects Associated with the Consumption of Some Feminine Intimate Care Products

Challenges
  • Number of New Entrants in the Market with Low Quality and Low Price Feminine Intimate Care Products


Key Target Audience
Feminine Intimate Care Manufacturers, Feminine Intimate Care Industry Association, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Wash
  • Wipes
  • Moisturizers & Creams
  • Shaving Gels
  • Others
By Distribution Channel
  • Online Retailers
  • Hypermarket
  • Specialty Store

By Form
  • Liquid
  • Gel
  • Foam
  • Others

By End User
  • Women
  • Female Teens

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Need for the Intimate Health Care to Avoid any Infections and other Serious Disease
      • 3.2.2. Growing Awareness about the Intimae Health Care
    • 3.3. Market Challenges
      • 3.3.1. Number of New Entrants in the Market with Low Quality and Low Price Feminine Intimate Care Products
    • 3.4. Market Trends
      • 3.4.1. Increasing Use of Intimate Wash Products Among Women
      • 3.4.2. Rising Online Availability of Feminine Intimate Care Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Feminine Intimate Care, by Type, Distribution Channel, Form, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Feminine Intimate Care (Value)
      • 5.2.1. Global Feminine Intimate Care by: Type (Value)
        • 5.2.1.1. Wash
        • 5.2.1.2. Wipes
        • 5.2.1.3. Moisturizers & Creams
        • 5.2.1.4. Shaving Gels
        • 5.2.1.5. Others
      • 5.2.2. Global Feminine Intimate Care by: Distribution Channel (Value)
        • 5.2.2.1. Online Retailers
        • 5.2.2.2. Hypermarket
        • 5.2.2.3. Specialty Store
      • 5.2.3. Global Feminine Intimate Care by: Form (Value)
        • 5.2.3.1. Liquid
        • 5.2.3.2. Gel
        • 5.2.3.3. Foam
        • 5.2.3.4. Others
      • 5.2.4. Global Feminine Intimate Care by: End User (Value)
        • 5.2.4.1. Women
        • 5.2.4.2. Female Teens
      • 5.2.5. Global Feminine Intimate Care Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Feminine Intimate Care: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Canesten) (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. The Procter & Gamble Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Unilever (HUL) (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanofi (Lactacyd) (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Himalaya Drug Company (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Unicharm Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kimberly-Clark Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nölken Hygiene Products GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Femina (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Feminine Intimate Care Sale, by Type, Distribution Channel, Form, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Feminine Intimate Care (Value)
      • 7.2.1. Global Feminine Intimate Care by: Type (Value)
        • 7.2.1.1. Wash
        • 7.2.1.2. Wipes
        • 7.2.1.3. Moisturizers & Creams
        • 7.2.1.4. Shaving Gels
        • 7.2.1.5. Others
      • 7.2.2. Global Feminine Intimate Care by: Distribution Channel (Value)
        • 7.2.2.1. Online Retailers
        • 7.2.2.2. Hypermarket
        • 7.2.2.3. Specialty Store
      • 7.2.3. Global Feminine Intimate Care by: Form (Value)
        • 7.2.3.1. Liquid
        • 7.2.3.2. Gel
        • 7.2.3.3. Foam
        • 7.2.3.4. Others
      • 7.2.4. Global Feminine Intimate Care by: End User (Value)
        • 7.2.4.1. Women
        • 7.2.4.2. Female Teens
      • 7.2.5. Global Feminine Intimate Care Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Feminine Intimate Care: by Type(USD Million)
  • Table 2. Feminine Intimate Care Wash , by Region USD Million (2015-2020)
  • Table 3. Feminine Intimate Care Wipes , by Region USD Million (2015-2020)
  • Table 4. Feminine Intimate Care Moisturizers & Creams , by Region USD Million (2015-2020)
  • Table 5. Feminine Intimate Care Shaving Gels , by Region USD Million (2015-2020)
  • Table 6. Feminine Intimate Care Others , by Region USD Million (2015-2020)
  • Table 7. Feminine Intimate Care: by Distribution Channel(USD Million)
  • Table 8. Feminine Intimate Care Online Retailers , by Region USD Million (2015-2020)
  • Table 9. Feminine Intimate Care Hypermarket , by Region USD Million (2015-2020)
  • Table 10. Feminine Intimate Care Specialty Store , by Region USD Million (2015-2020)
  • Table 11. Feminine Intimate Care: by Form(USD Million)
  • Table 12. Feminine Intimate Care Liquid , by Region USD Million (2015-2020)
  • Table 13. Feminine Intimate Care Gel , by Region USD Million (2015-2020)
  • Table 14. Feminine Intimate Care Foam , by Region USD Million (2015-2020)
  • Table 15. Feminine Intimate Care Others , by Region USD Million (2015-2020)
  • Table 16. Feminine Intimate Care: by End User(USD Million)
  • Table 17. Feminine Intimate Care Women , by Region USD Million (2015-2020)
  • Table 18. Feminine Intimate Care Female Teens , by Region USD Million (2015-2020)
  • Table 19. South America Feminine Intimate Care, by Country USD Million (2015-2020)
  • Table 20. South America Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 21. South America Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 22. South America Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 23. South America Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 24. Brazil Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 25. Brazil Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 26. Brazil Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 27. Brazil Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 28. Argentina Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 29. Argentina Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 30. Argentina Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 31. Argentina Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 32. Rest of South America Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 34. Rest of South America Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 35. Rest of South America Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 36. Asia Pacific Feminine Intimate Care, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 39. Asia Pacific Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 40. Asia Pacific Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 41. China Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 42. China Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 43. China Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 44. China Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 45. Japan Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 46. Japan Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 47. Japan Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 48. Japan Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 49. India Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 50. India Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 51. India Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 52. India Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 53. South Korea Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 54. South Korea Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 55. South Korea Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 56. South Korea Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 57. Taiwan Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 58. Taiwan Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 59. Taiwan Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 60. Taiwan Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 61. Australia Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 62. Australia Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 63. Australia Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 64. Australia Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 69. Europe Feminine Intimate Care, by Country USD Million (2015-2020)
  • Table 70. Europe Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 71. Europe Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 72. Europe Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 73. Europe Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 74. Germany Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 75. Germany Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 76. Germany Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 77. Germany Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 78. France Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 79. France Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 80. France Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 81. France Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 82. Italy Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 83. Italy Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 84. Italy Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 85. Italy Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 86. United Kingdom Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 88. United Kingdom Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 89. United Kingdom Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 90. Netherlands Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 91. Netherlands Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 92. Netherlands Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 93. Netherlands Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 94. Rest of Europe Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 96. Rest of Europe Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 97. Rest of Europe Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 98. MEA Feminine Intimate Care, by Country USD Million (2015-2020)
  • Table 99. MEA Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 100. MEA Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 101. MEA Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 102. MEA Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 103. Middle East Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 104. Middle East Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 105. Middle East Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 106. Middle East Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 107. Africa Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 108. Africa Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 109. Africa Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 110. Africa Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 111. North America Feminine Intimate Care, by Country USD Million (2015-2020)
  • Table 112. North America Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 113. North America Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 114. North America Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 115. North America Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 116. United States Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 117. United States Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 118. United States Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 119. United States Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 120. Canada Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 121. Canada Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 122. Canada Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 123. Canada Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 124. Mexico Feminine Intimate Care, by Type USD Million (2015-2020)
  • Table 125. Mexico Feminine Intimate Care, by Distribution Channel USD Million (2015-2020)
  • Table 126. Mexico Feminine Intimate Care, by Form USD Million (2015-2020)
  • Table 127. Mexico Feminine Intimate Care, by End User USD Million (2015-2020)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Feminine Intimate Care: by Type(USD Million)
  • Table 139. Feminine Intimate Care Wash , by Region USD Million (2021-2026)
  • Table 140. Feminine Intimate Care Wipes , by Region USD Million (2021-2026)
  • Table 141. Feminine Intimate Care Moisturizers & Creams , by Region USD Million (2021-2026)
  • Table 142. Feminine Intimate Care Shaving Gels , by Region USD Million (2021-2026)
  • Table 143. Feminine Intimate Care Others , by Region USD Million (2021-2026)
  • Table 144. Feminine Intimate Care: by Distribution Channel(USD Million)
  • Table 145. Feminine Intimate Care Online Retailers , by Region USD Million (2021-2026)
  • Table 146. Feminine Intimate Care Hypermarket , by Region USD Million (2021-2026)
  • Table 147. Feminine Intimate Care Specialty Store , by Region USD Million (2021-2026)
  • Table 148. Feminine Intimate Care: by Form(USD Million)
  • Table 149. Feminine Intimate Care Liquid , by Region USD Million (2021-2026)
  • Table 150. Feminine Intimate Care Gel , by Region USD Million (2021-2026)
  • Table 151. Feminine Intimate Care Foam , by Region USD Million (2021-2026)
  • Table 152. Feminine Intimate Care Others , by Region USD Million (2021-2026)
  • Table 153. Feminine Intimate Care: by End User(USD Million)
  • Table 154. Feminine Intimate Care Women , by Region USD Million (2021-2026)
  • Table 155. Feminine Intimate Care Female Teens , by Region USD Million (2021-2026)
  • Table 156. South America Feminine Intimate Care, by Country USD Million (2021-2026)
  • Table 157. South America Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 158. South America Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 159. South America Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 160. South America Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 161. Brazil Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 162. Brazil Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 163. Brazil Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 164. Brazil Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 165. Argentina Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 166. Argentina Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 167. Argentina Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 168. Argentina Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 169. Rest of South America Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 170. Rest of South America Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 171. Rest of South America Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 172. Rest of South America Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 173. Asia Pacific Feminine Intimate Care, by Country USD Million (2021-2026)
  • Table 174. Asia Pacific Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 175. Asia Pacific Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 176. Asia Pacific Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 177. Asia Pacific Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 178. China Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 179. China Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 180. China Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 181. China Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 182. Japan Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 183. Japan Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 184. Japan Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 185. Japan Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 186. India Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 187. India Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 188. India Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 189. India Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 190. South Korea Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 191. South Korea Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 192. South Korea Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 193. South Korea Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 194. Taiwan Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 195. Taiwan Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 196. Taiwan Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 197. Taiwan Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 198. Australia Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 199. Australia Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 200. Australia Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 201. Australia Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 206. Europe Feminine Intimate Care, by Country USD Million (2021-2026)
  • Table 207. Europe Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 208. Europe Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 209. Europe Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 210. Europe Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 211. Germany Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 212. Germany Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 213. Germany Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 214. Germany Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 215. France Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 216. France Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 217. France Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 218. France Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 219. Italy Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 220. Italy Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 221. Italy Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 222. Italy Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 223. United Kingdom Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 224. United Kingdom Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 225. United Kingdom Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 226. United Kingdom Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 227. Netherlands Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 228. Netherlands Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 229. Netherlands Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 230. Netherlands Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 231. Rest of Europe Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 232. Rest of Europe Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 233. Rest of Europe Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 234. Rest of Europe Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 235. MEA Feminine Intimate Care, by Country USD Million (2021-2026)
  • Table 236. MEA Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 237. MEA Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 238. MEA Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 239. MEA Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 240. Middle East Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 241. Middle East Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 242. Middle East Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 243. Middle East Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 244. Africa Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 245. Africa Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 246. Africa Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 247. Africa Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 248. North America Feminine Intimate Care, by Country USD Million (2021-2026)
  • Table 249. North America Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 250. North America Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 251. North America Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 252. North America Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 253. United States Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 254. United States Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 255. United States Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 256. United States Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 257. Canada Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 258. Canada Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 259. Canada Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 260. Canada Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 261. Mexico Feminine Intimate Care, by Type USD Million (2021-2026)
  • Table 262. Mexico Feminine Intimate Care, by Distribution Channel USD Million (2021-2026)
  • Table 263. Mexico Feminine Intimate Care, by Form USD Million (2021-2026)
  • Table 264. Mexico Feminine Intimate Care, by End User USD Million (2021-2026)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Feminine Intimate Care: by Type USD Million (2015-2020)
  • Figure 5. Global Feminine Intimate Care: by Distribution Channel USD Million (2015-2020)
  • Figure 6. Global Feminine Intimate Care: by Form USD Million (2015-2020)
  • Figure 7. Global Feminine Intimate Care: by End User USD Million (2015-2020)
  • Figure 8. South America Feminine Intimate Care Share (%), by Country
  • Figure 9. Asia Pacific Feminine Intimate Care Share (%), by Country
  • Figure 10. Europe Feminine Intimate Care Share (%), by Country
  • Figure 11. MEA Feminine Intimate Care Share (%), by Country
  • Figure 12. North America Feminine Intimate Care Share (%), by Country
  • Figure 13. Global Feminine Intimate Care share by Players 2020 (%)
  • Figure 14. Global Feminine Intimate Care share by Players (Top 3) 2020(%)
  • Figure 15. Global Feminine Intimate Care share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bayer AG (Canesten) (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Bayer AG (Canesten) (Germany) Revenue: by Geography 2020
  • Figure 19. The Procter & Gamble Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. The Procter & Gamble Company (United States) Revenue: by Geography 2020
  • Figure 21. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 22. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 23. Unilever (HUL) (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Unilever (HUL) (United Kingdom) Revenue: by Geography 2020
  • Figure 25. Sanofi (Lactacyd) (France) Revenue, Net Income and Gross profit
  • Figure 26. Sanofi (Lactacyd) (France) Revenue: by Geography 2020
  • Figure 27. Himalaya Drug Company (India) Revenue, Net Income and Gross profit
  • Figure 28. Himalaya Drug Company (India) Revenue: by Geography 2020
  • Figure 29. Unicharm Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Unicharm Corporation (Japan) Revenue: by Geography 2020
  • Figure 31. Kimberly-Clark Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Kimberly-Clark Corporation (United States) Revenue: by Geography 2020
  • Figure 33. Nölken Hygiene Products GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Nölken Hygiene Products GmbH (Germany) Revenue: by Geography 2020
  • Figure 35. Femina (Israel) Revenue, Net Income and Gross profit
  • Figure 36. Femina (Israel) Revenue: by Geography 2020
  • Figure 37. Global Feminine Intimate Care: by Type USD Million (2021-2026)
  • Figure 38. Global Feminine Intimate Care: by Distribution Channel USD Million (2021-2026)
  • Figure 39. Global Feminine Intimate Care: by Form USD Million (2021-2026)
  • Figure 40. Global Feminine Intimate Care: by End User USD Million (2021-2026)
  • Figure 41. South America Feminine Intimate Care Share (%), by Country
  • Figure 42. Asia Pacific Feminine Intimate Care Share (%), by Country
  • Figure 43. Europe Feminine Intimate Care Share (%), by Country
  • Figure 44. MEA Feminine Intimate Care Share (%), by Country
  • Figure 45. North America Feminine Intimate Care Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bayer AG (Canesten) (Germany)
  • The Procter & Gamble Company (United States)
  • Johnson & Johnson (United States)
  • Unilever (HUL) (United Kingdom)
  • Sanofi (Lactacyd) (France)
  • Himalaya Drug Company (India)
  • Unicharm Corporation (Japan)
  • Kimberly-Clark Corporation (United States)
  • Nölken Hygiene Products GmbH (Germany)
  • Femina (Israel)
Select User Access Type

Key Highlights of Report


Jul 2021 215 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bayer AG (Canesten) (Germany), The Procter & Gamble Company (United States), Johnson & Johnson (United States), Unilever (HUL) (United Kingdom), Sanofi (Lactacyd) (France), Himalaya Drug Company (India), Unicharm Corporation (Japan), Kimberly-Clark Corporation (United States), Nölken Hygiene Products GmbH (Germany) and Femina (Israel) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Feminine Intimate Care Market to reach USD Million by 2026.

Know More About Global Feminine Intimate Care Report?